Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-20-043020
Filing Date
2020-02-20
Accepted
2020-02-20 12:25:17
Documents
4

Document Format Files

Seq Description Document Type Size
1 8-K d890351d8k.htm 425 16138
2 EX-99.1 d890351dex991.htm EX-99.1 29081
3 GRAPHIC g890351dsp001.jpg GRAPHIC 3110
4 GRAPHIC g890351dsp001a.jpg GRAPHIC 3608
  Complete submission text file 0001193125-20-043020.txt   56447
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Subject) CIK: 0000835887 (see all company filings)

EIN.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-23143 | Film No.: 20633633
SIC: 2834 Pharmaceutical Preparations

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filed by) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances